1. Home
  2. NVCT vs CURR Comparison

NVCT vs CURR Comparison

Compare NVCT & CURR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCT
  • CURR
  • Stock Information
  • Founded
  • NVCT 2020
  • CURR 2013
  • Country
  • NVCT United States
  • CURR Singapore
  • Employees
  • NVCT N/A
  • CURR N/A
  • Industry
  • NVCT Medicinal Chemicals and Botanical Products
  • CURR Business Services
  • Sector
  • NVCT Health Care
  • CURR Consumer Discretionary
  • Exchange
  • NVCT Nasdaq
  • CURR Nasdaq
  • Market Cap
  • NVCT 167.0M
  • CURR 151.4M
  • IPO Year
  • NVCT 2022
  • CURR N/A
  • Fundamental
  • Price
  • NVCT $6.40
  • CURR $1.65
  • Analyst Decision
  • NVCT Strong Buy
  • CURR Strong Buy
  • Analyst Count
  • NVCT 3
  • CURR 1
  • Target Price
  • NVCT $15.33
  • CURR $3.50
  • AVG Volume (30 Days)
  • NVCT 75.1K
  • CURR 248.5K
  • Earning Date
  • NVCT 11-04-2025
  • CURR 08-04-2025
  • Dividend Yield
  • NVCT N/A
  • CURR N/A
  • EPS Growth
  • NVCT N/A
  • CURR N/A
  • EPS
  • NVCT N/A
  • CURR N/A
  • Revenue
  • NVCT N/A
  • CURR $41,092,419.00
  • Revenue This Year
  • NVCT N/A
  • CURR N/A
  • Revenue Next Year
  • NVCT N/A
  • CURR $14.56
  • P/E Ratio
  • NVCT N/A
  • CURR N/A
  • Revenue Growth
  • NVCT N/A
  • CURR N/A
  • 52 Week Low
  • NVCT $4.44
  • CURR $0.33
  • 52 Week High
  • NVCT $11.80
  • CURR $7.08
  • Technical
  • Relative Strength Index (RSI)
  • NVCT 44.54
  • CURR 47.65
  • Support Level
  • NVCT $6.32
  • CURR $1.60
  • Resistance Level
  • NVCT $6.90
  • CURR $1.80
  • Average True Range (ATR)
  • NVCT 0.34
  • CURR 0.13
  • MACD
  • NVCT 0.05
  • CURR -0.02
  • Stochastic Oscillator
  • NVCT 36.71
  • CURR 26.37

About NVCT Nuvectis Pharma Inc.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

About CURR Currenc Group Inc. Ordinary Shares

Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The Company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It generates the majority of its geographic revenue from Malaysia.

Share on Social Networks: